Enovis Corporation
General ticker "ENOV" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.0B (TTM average)
Enovis Corporation follows the US Stock Market performance with the rate: 9.7%.
Estimated limits based on current volatility of 2.4%: low 28.79$, high 30.21$
Factors to consider:
- Total employees count: 7367 (+12.5%) as of 2024
- US accounted for 59.1% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Acquisition/divestiture risks, Supply chain disruptions, Economic downturns and volatility, Market competition, Regulatory and compliance
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [27.30$, 50.85$]
- 2025-12-31 to 2026-12-31 estimated range: [25.29$, 47.44$]
Financial Metrics affecting the ENOV estimates:
- Negative: with PPE of 15.4 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of 0.05 <= 0.28
- Negative: negative Net income
- Positive: 0 < Industry earnings per price (median), % of 2.74
- Positive: 41.86 < Shareholder equity ratio, % of 54.30 <= 63.39
- Positive: 0.33 < Operating cash flow per share per price, % of 4.71
- Positive: 2.97 < Industry operating profit margin (median), % of 6.90
Short-term ENOV quotes
Long-term ENOV plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,599.81MM | $1,707.20MM | $2,107.62MM |
| Operating Expenses | $1,670.98MM | $1,772.91MM | $2,883.34MM |
| Operating Income | $-71.18MM | $-65.71MM | $-775.72MM |
| Non-Operating Income | $69.11MM | $-1.42MM | $-47.20MM |
| Interest Expense | $24.05MM | $19.75MM | $57.10MM |
| R&D Expense | $60.83MM | $75.33MM | $91.30MM |
| Income(Loss) | $-2.07MM | $-67.13MM | $-822.92MM |
| Taxes | $36.12MM | $-13.29MM | $4.49MM |
| Other Income(Loss) | $26.43MM | $21.11MM | $2.60MM |
| Profit(Loss)* | $-12.33MM | $-33.26MM | $-825.49MM |
| Stockholders Equity | $3,448.09MM | $3,418.39MM | $2,562.26MM |
| Inventory | $426.64MM | $468.83MM | $547.12MM |
| Assets | $4,273.25MM | $4,509.33MM | $4,718.78MM |
| Operating Cash Flow | $-55.86MM | $134.99MM | $113.50MM |
| Capital expenditure | $105.45MM | $122.22MM | $180.71MM |
| Investing Cash Flow | $-176.39MM | $-242.47MM | $-955.47MM |
| Financing Cash Flow | $-465.13MM | $127.80MM | $846.82MM |
| Earnings Per Share** | $-0.23 | $-0.61 | $-14.93 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.